Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab-Reference-Cited by-同舟云学术

Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab

Published:2023-01-04 Issue:5 Volume:48 Page:535-536
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

López Sanz Pablo¹^ORCID,Guzmán Pérez Marta²,Azaña Defez José Manuel¹,Guerrero Ramírez Claudia¹,Manso Córdoba Silvia¹,Alfaro Martínez María Encarnación¹

Affiliation:

1. Departments of Dermatology and Internal Medicine, University General Hospital of Albacete , Albacete , Spain

2. Internal Medicine, University General Hospital of Albacete , Albacete , Spain

Abstract

Hidradenitis suppurativa (HS) as a paradoxical adverse event (PAE) from using anti-interleukin (IL)-1 has not been reported in the literature, to our knowledge. We herein report a case of paradoxical HS as a result of use of anti-IL-1 agents for mevalonate kinase deficiency disease that was successfully treated with the addition of ustekinumab.

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://academic.oup.com/ced/advance-article-pdf/doi/10.1093/ced/llad003/49157729/llad003.pdf

Reference5 articles.

1. Paradoxical reactions to biologicals in chronic inflammatory systemic diseases;Kremenevski;Dtsch Arztebl Int,2022

2. An update on hidradenitis suppurativa (Part I): epidemiology, clinical aspects, and definition of disease severity;Martorell;Actas Dermosifiliogr,2015

3. New and emerging targeted therapies for hidradenitis suppurativa;Markota Čagalj;Int J Mol Sci,2022

4. Bacteria induce skin regeneration via IL-1β signaling;Wang;Cell Host Microbe,2021

5. High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa;Jiang;Br J Dermatol,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anakinra/canakinumab;Reactions Weekly;2023-07-22

2. Reply to ‘Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on “Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab”’;Clinical and Experimental Dermatology;2023-04-25

3. Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature;Medicina;2023-04-20

4. Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on ‘Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab’;Clinical and Experimental Dermatology;2023-03-08